Stay updated on L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial page.

Latest updates to the L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check46 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new details about the study on Lung Adenocarcinoma, such as the EudraCT number and the involvement of collaborators. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference44%
- Check54 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check97 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check111 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial page.